Articles by tag: rnai-therapy

RNA interference-based drug for hyperlipoproteinemia(a) approved by FDA

FDA approved the world's first siRNA drug to reduce lipoprotein(a) by more than 80%. Learn about the mechanism of action, efficacy, and impact on cardiology. Read details.